Thomas Tobin, Veterinarian, Dublin (1964), PhD, U. Toronto, 1970. Researched Na K ATPase until 1974, Associate Prof., MSU Vet. School. In 75 Prof., U of Ky, wrote “Drugs and the Performance Horse”, 1981, published the threshold for Lasix. 1988, introduced ELISA tests to horseracing, now the Neogen line of racing ELISA tests. 1999, patented Diclazuril for Equine Protozoal myelitis, (EPM) now Bayer Marquis, first FDA approved treatment for EPM. 2001, worked on the Mare Reproductive Loss Syndrome, copyrighting the unique probabilistic mechanism for MRLS. More recently focused on synthesis and certification of reference standards/internal standards for equine therapeutic medication regulation, www.thomastobin.com.